Coronavirus Disease 2019 (COVID-19) Outbreak Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) P.1 Lineage in a Long-Term Care Home After Implementation of a Vaccination Program—Ontario, Canada, April–May 2021 | Zendy

Chantal Williams | Zendy; Dana Al-Bargash | Zendy; Celeste Macalintal | Zendy; Rebecca Stuart | Zendy; Anu Seth | Zendy; Julienne Latham | Zendy; Leah Gitterman | Zendy; Stephanie Fedsin | Zendy; Marion Godoy | Zendy; Robert Kozak | Zendy; Jennifer L. Guthrie | Zendy; Heidi Wood | Zendy; Allison McGeer | Zendy; Susy Hota | Zendy; Elizabeth Rea | Zendy

Open Access

Coronavirus Disease 2019 (COVID-19) Outbreak Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) P.1 Lineage in a Long-Term Care Home After Implementation of a Vaccination Program—Ontario, Canada, April–May 2021

Author(s) -

Chantal Williams,

Dana Al-Bargash,

Celeste Macalintal,

Rebecca Stuart,

Anu Seth,

Julienne Latham,

Leah Gitterman,

Stephanie Fedsin,

Marion Godoy,

Robert Kozak,

Jennifer L. Guthrie,

Heidi Wood,

Allison McGeer,

Susy Hota,

Elizabeth Rea

Publication year - 2021

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciab617

Subject(s) - medicine , outbreak , coronavirus , vaccination , infection control , virology , betacoronavirus , covid-19 , confidence interval , pediatrics , disease , intensive care medicine , infectious disease (medical specialty)

In a P.1 coronavirus disease 2019 (COVID-19) outbreak in a long-term care home, vaccine effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was 52.5% (95% confidence interval: 26.9%–69.1%) in residents and 66.2% (2.3%–88.3%) in staff. Vaccine effectiveness against severe illness was 78.6% (47.9%–91.2%) in residents. Two of 19 vaccinated resident case patients died. Outbreak management required both vaccination and infection control measures.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research